gsk boston - Search News

News

GSK to buy liver disease drug from Boston Pharmaceuticals

GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion

The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their exclusivity periods.

· 6h · on MSN

PMLive · 34m

GSK to acquire Boston’s liver disease candidate efimosfermin in deal worth up to $2bn

Medical Dialogues · 1h

GSK to acquire liver disease drug Efimosfermin for up to USD 2 billion

Pharmabiz7h

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD: London, UK Thursday, May 15, 2025, ...

Five things: World Cup game prices, GSK, Cape Cod's name and an economic introduction

Here are the five things you need to know in local business news to start your busy Thursday, including World Cup game prices, GSK's latest buy, how Cape Cod got its name and economic experts offer ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

GSK to buy liver disease drug from Boston Pharmaceuticals

Trending now